^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    DecisionDx®-UM

    Company:
    Castle Biosci
    Type:
    Laboratory Developed Test
    Related tests:

    Details

    Evidence
    News
    DecisionDx-UM is a proprietary GEP (gene expression profile) test that helps healthcare providers predict the risk of metastasis in patients with uveal melanoma.
    Cancer:
    Uveal Melanoma
    Method:
    RT-PCR
    Confirmatory trial(s)
    CLEAR
    ,
    NCT02376920
    |
    J Oncol